a. All the rights related to the contents ofthis website, including but not limited to: data, text, works of fine art,graphics, images, sound, video, LOGO, creative overall appearance of thewebsite, etc., belong to LinkZill. All the rights are protected by the laws andregulations of the People's Republic of China and international conventions.LinkZill or the contents providers have registered the trademarks on thiswebsite, thus protected by the laws and regulations of the People's Republic ofChina and international conventions.
b. Without the prior written consent and permissionof LinkZill or the related right holders, no unit or natural person shall copy,reproduce, disseminate, publish, repost, adapt or display the content of thiswebsite in any way. Any unauthorized use of this website or its contents willviolate the Copyright Law of the People's Republic of China, other relatedlaws, regulations, and international conventions. LinkZill fully reserves theright to pursue legal actions on legal liabilities.
c. The content of this website is availablefor reading. The documents on this website are distributable for non-commercialinformation reference, with citations leading to LinkZill. The exchange,modification, sale, or dissemination of any content on this site is notpermitted. The press releases and other public documents are available forpublic communication with citations leading to the source of information.Contact the responsible personnel of the website if available before using anycontent.
Declaration
a. LinkZill will ensure the accuracy of thecontent of this website. Related content may update or change due to the needsof the market and products developments. Sorry for the inconvenience.
b. The website domain name of LinkZill'swebsite is www.linkzill.com. We solemnly remind you: do not access counterfeitwebsites to avoid losses.
Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.
